Biotechnology Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Axsome Therapeutics, Inc. (AXSM) July 1, 2022
Biotechnology CLASS ACTION UPDATE for RSKD, AXSM and YEXT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders June 30, 2022
Biotechnology REDUCE-IT Exploratory Post Hoc Biomarker Sub-Analysis Shows Relatively Small Changes in Inflammatory Markers Between Icosapent Ethyl and Placebo June 30, 2022
Search
biotech stock market
